CN Stock MarketDetailed Quotes

Chengdu Easton Biopharmaceuticals (688513)

Watchlist
  • 59.00
  • -0.54-0.91%
Market Closed Jan 16 15:00 CST
10.42BMarket Cap43.16P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chengdu Easton Biopharmaceuticals (688513) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Preparation sales515.38M78.75%
Bulk drug sales60.34M9.22%
技术服务及转让44.47M6.79%
CMO/CDMO26.25M4.01%
Other8.01M1.22%

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry1.35B99.86%
Other business1.84M0.14%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
East China region240.49M36.75%
Southwest area125.35M19.15%
North China98.78M15.09%
South China78.2M11.95%
Central China49.97M7.64%
Northeast area26.82M4.10%
Northwest region22.98M3.51%
Overseas region11.85M1.81%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +7.36%
Sample Name
Sample Code
 +3.57%
Sample Name
Sample Code
 +2.22%
4
Broadcom
AVGO
+1.17%
5
Microsoft
MSFT
+1.07%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -